In preclinical tumor models, IMANs enhanced effector cell recruitment, resulting in increased tumor cell death. Additionally, they synergised with CAR-T cells to enhance tumor clearance in models of ...

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO® (faricimab injection) Pre-Filled Syringe (PFS) is now publicly funded though the Ontario Drug Benefit Program.1 ...

Datavault AI Inc. ("Datavault AI" or the "Company") , a leader in AI-driven blockchain solutions focusing on data monetization, asset tokenization, and secure digital marketplaces, today announced ...

New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] ...

Thanks to SMR, this is quickly changing, and a long list of nuclear reactors has now popped up all over North America (as well as Europe). By 2050, leading companies in the industry expect North ...

What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...

In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...

CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

Michael Buck, PhD, professor of biochemistry in the Jacobs School, recently received NIH funding to explore how molecular readers of DNA access and activate seemingly hidden genes.

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy ...